$84.910
-3.524 (-4.15%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
ARWR Prediction & Forecast by Similar Chart Analysis
Alphio's ARWR stock price prediction model matches the current Arrowhead Pharmaceuticals, Inc. tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $84.82 (-0.11%). The 1-week path is $83.59 (-1.56%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Arrowhead Pharmaceuticals, Inc. Stock?
Arrowhead Pharmaceuticals Inc is a good buy right now due to its recent positive clinical trial results, which showed triglyceride reductions of 79% and 81%, and a strong financial position with $1.6 billion in cash and investments. The current price of $84.91 is significantly lower than the analyst price target of $120, indicating a potential upside of 41%. However, the main risk is the negative earnings per share (EPS) of -1.36 reported for the last quarter, which highlights ongoing financial challenges.
ARWR stock price ended at $84.91 on Friday, after losing -4.15%
Arrowhead Pharmaceuticals, Inc. (ARWR) last closed at $84.91, losing -4.15%. These facts feed the 1-day and 1-week ARWR price prediction above.
Forecast Drivers
Arrowhead Pharmaceuticals, Inc. (ARWR) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches ARWR, ranked by similarity.
Seasonality analysis for ARWR
Historically the probability of a positive August return for ARWR is 50.79%. January offers the highest probability of a positive month at 59.02%, while March is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for ARWR
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $18.26 | $19.53 | $23.91 | -77.00% |
| Sep 2026 | $19.51 | $19.53 | $19.70 | -77.00% |
| Oct 2026 | $15.27 | $16.90 | $20.94 | -80.10% |
| Nov 2026 | $16.44 | $18.99 | $20.96 | -77.63% |
| Dec 2026 | $14.63 | $18.75 | $20.14 | -77.92% |
In 2026, Arrowhead Pharmaceuticals, Inc. (ARWR) is projected to range from $14.63 to $23.91.
Arrowhead Pharmaceuticals, Inc. 2026 monthly forecast
In Aug 2026, Arrowhead Pharmaceuticals, Inc. is projected to average $19.53, with a low of $18.26 and high of $23.91.
In Sep 2026, Arrowhead Pharmaceuticals, Inc. is projected to average $19.53, with a low of $19.51 and high of $19.70.
In Oct 2026, Arrowhead Pharmaceuticals, Inc. is projected to average $16.90, with a low of $15.27 and high of $20.94.
In Nov 2026, Arrowhead Pharmaceuticals, Inc. is projected to average $18.99, with a low of $16.44 and high of $20.96.
In Dec 2026, Arrowhead Pharmaceuticals, Inc. is projected to average $18.75, with a low of $14.63 and high of $20.14.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.